Intensity Therapeutics - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi INTS
The Intensity Therapeutics (INTS) EBITDA chart is based on management's consistent execution of clinical plans. High authority in oncology, driven by direct tumor drug delivery methods, and complete independence from GDP phases ensure business resilience. This trend is confirmed by the fact that 0.00 forms the current metric, clearly demonstrating the company's real cash flow.
Intensity Therapeutics, Inc. - rincian analitis lan metrik utama (INTS)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Intensity Therapeutics|INTS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Intensity Therapeutics Inc|INTS - Utang perusahaan|Rasio utang marang nilai buku Intensity Therapeutics|INTS - Utang jangka dawa perusahaan|Utang jangka cendhak Intensity Therapeutics|Likuiditas kritis intensitytherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
INTS - Penghasilan resik|Bathi resik mangsa ngarep Intensity Therapeutics|INTS - Pangali P/E|Pangali mangsa ngarep rega marang bathi Intensity Therapeutics Inc|INTS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intensity Therapeutics|INTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Intensity Therapeutics|INTS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan intensitytherapeutics.com|INTS - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Intensity Therapeutics
Analisis kabeh metrik perusahaan:Intensity Therapeutics - INTS
Developing the DATH platform for cancer therapy requires colossal expenditures, making the analysis of operating cash flow critical. This EBITDA chart captures the actual cash generated by the business excluding accounting adjustments, allowing for an assessment of Intensity Therapeutics (INTS) resilience to recession and its ability to fund R&D investments without a critical dependence on external borrowings.
Pesaing Intensity Therapeutics (INTS)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (Innate Pharma S.A) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|Cue Biopharma, Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology|sonnetbio.com (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LIMN (Liminatus Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA Lava Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NextCure (NXTC)|LPTX: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|Gritstone Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi kinetabio.com KA|NexImmune (NEXI) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi TSBX|Bathi operasional sadurunge ngurangi amortisasi VCNX|HARP (Harpoon Therapeutics Corp) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi
